89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Systemic Sclerosis
Related studies linked through entity extraction aliases.
Chest CT Biomarkers as Prognostic Predictors in SSc-ILD
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- Status
- RECRUITING
- Phase
- NA
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
- Status
- RECRUITING
- Phase
- NA
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- NA
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
- Status
- RECRUITING
- Phase
- PHASE3
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
- Status
- COMPLETED
- Phase
- N/A